Clinical Trials Browser

Recurrence × Alpelisib × 90 days × Clear all

NCT05154487 2026-03-03

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

Phase 2 Active not recruiting

Recurrence